MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20249677

December 1, 2024

Drug Information

盐酸多巴酚丁胺注射液

注射剂

20ml:250mg(按 C₁₈H₂₃NO₃计)

化学药品

December 1, 2024

Company Information

Applicant Company

西安沣京工业园标准化厂房一期建设区

Manufacturing Company

西安沣京工业园标准化厂房一期建设区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.